Nashville, Tenn.-based Envision Healthcare rejected two of KKR's offers to acquire the company before accepting a $9.9 billion bid, the Nashville Business Journal reports.
Here's what you should know:
1, Envision's board rejected offers of $45.25 per share and $45.75 per share before agreeing to a $46 per share offer.
2. Envision shareholders approved the sale last week. It still must clear the Securities and Exchange Commission.
3. Once the sale closes, KKR will take Envision private.
4. Envision CEO Chris Holden will remain CEO after the sale. He said KKR won't change how the company operates.